Optical transfer diagnosis of pigmented lesions: a pilot study

• Published in: Skin research and technology Vol. 15; no. 3; pp. 330 - 337
• Main Authors: Swanson, David L., Laman, Susan D., Biryulina, Marina, Nielsen, Kristian P., Ryzhikov, Gennady, Stamnes, Jakob J., Hamre, Borge, Zhao, Lu, Castellana, Frank S., Stamnes, Knut
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Publishing Ltd 01.08.2009
• Subjects: automation; Biomarkers, Tumor - analysis; diagnosis; diagnostic imaging; Female; Humans; Male; melanoma; Melanoma - diagnosis; Melanoma - metabolism; Pigmentation Disorders - diagnosis; Pigmentation Disorders - metabolism; Pilot Projects; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms - diagnosis; Skin Neoplasms - metabolism; Spectrum Analysis - methods
• ISSN: 0909-752X; 1600-0846
• DOI: 10.1111/j.1600-0846.2009.00367.x

Objective: To evaluate the potential of a novel imaging technology, optical transfer diagnosis (OTD), for differentiation of benign from malignant pigmented melanocytic lesions. Design: Patients with pigmented lesions suspicious for melanoma were referred for OTD. After scanning, lesions were biopsied for histopathologic examination, each by two separate dermatopathologists. To create morphologic–physiologic maps, the imaging system used the morphologic and physiologic parameters derived from prediction models of light absorption and scattering by chromophores such as hemoglobin, keratin, and melanin at different epidermal and dermal depths. The relative entropies were analyzed for output prediction of malignancy vs. nonmalignancy. Setting: General dermatology clinic in a tertiary care academic medical center. Patients: Fifty patients with suspected melanoma. Intervention: OTD of pigmented lesions suspicious for melanoma, followed by biopsies for histopathologic examination. Main outcome measures: Histopathologic confirmation of malignant lesions identified by OTD as melanoma. Results: Sixty‐three pigmented suspicious lesions were scanned before being biopsied for histopathologic examination by the two dermatopathologists. Of the 63 lesions, five were identified as melanoma and 58 were found to be benign (including three seborrheic keratoses and 55 melanocytic nevi). OTD was able to identify the malignant lesions with 100% sensitivity and 94.8–96.6% specificity. Conclusions: Further study is indicated, but this technology is a promising adjunct to clinical skin cancer screening. Additionally, if the physiologic prediction models can be validated, OTD may facilitate the noninvasive study of some aspects of cutaneous physiology.